Medicon Hellas S.A.
Research Medicon Hellas S.A. (MEDIC) on Bullrun: market cap EUR 13.75M, P/E 18.2, dividend yield 4.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMEDIC
- ExchangeAT
- CountryGreece
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 13.75M
- P/E18.2
- Dividend yield4.8%
- Financial periodFY2025
- RevenueEUR 17.95M
- Revenue growth-0.9%
- Net incomeEUR 1.77M
- Free cash flowEUR 2.91M
- Gross margin73.0%
Valuation Snapshot
latest market cap is EUR 13.75M; P/E is 18.2; dividend yield is 4.8%.
Peer valuation comparison
Latest P/E is 18.19x versus a Healthcare sector median of 21.8x (16.6% below).
Latest dividend yield is 4.82% versus a Healthcare sector median of 2.4% (100.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 17.95M | EUR 1.77M | EUR 2.91M | 73.0% | n/a | EUR 6.68M | n/a | EUR 19.76M |
| FY2024 | EUR 18.12M | EUR 1.33M | EUR 995.41K | 71.1% | n/a | EUR 8.51M | n/a | EUR 18.57M |
| FY2023 | EUR 18.12M | EUR 1.44M | -EUR 716.47K | 71.9% | n/a | EUR 5.46M | n/a | EUR 17.72M |
| FY2022 | EUR 20.77M | EUR 2.70M | EUR 840.69K | 74.5% | n/a | EUR 10.21M | n/a | EUR 17.51M |
| FY2021 | EUR 21.51M | EUR 3.24M | EUR 4.24M | 72.9% | n/a | EUR 10.36M | n/a | EUR 14.93M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-29 | EUR 13.75M | 18.2 | 4.8% | 0.15 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.15 EUR, yield 4.8%.
About Medicon Hellas S.A.
Medicon Hellas S.A. operates in the diagnostics industry that offers instruments, tests, and procedures to clinical and research labs in Greece and internationally. It manufactures, imports, and provides diagnostic and point-of-care test systems, molecular diagnostics, laboratory automation, workflow improvement, and software solutions and services to state and private hospitals and laboratories. The company also produces and exports clinical chemistry, hematology, and immunochemistry reagents.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Medicon Hellas S.A.'s market cap?
Medicon Hellas S.A.'s market capitalization is EUR 13.75M.
What is Medicon Hellas S.A.'s P/E ratio?
Medicon Hellas S.A.'s price-to-earnings (P/E) ratio is 18.2.
Does Medicon Hellas S.A. pay a dividend?
Medicon Hellas S.A. has a dividend yield of 4.8%.
What does Medicon Hellas S.A. do?
Medicon Hellas S.A. operates in the diagnostics industry that offers instruments, tests, and procedures to clinical and research labs in Greece and internationally. It manufactures, imports, and provides diagnostic and point-of-care test systems, molecular diagnostics, laboratory automation, workflow improvement, and software solutions and services to state and private hospitals and laboratories. The company also produces and exports clinical chemistry, hematology, and immunochemistry reagents.